Bharat Parenterals Ltd. (BPLPHARMA) Share Price Trades Within 2% of 52-Week High

Bharat Parenterals Ltd. Share Price stood at Rs 1,360 at the event time, with the stock trading within 2% of its 52-week high and a market capitalisation of Rs 930.04 crore.

Bharat Parenterals Ltd. Share Price was Rs 1,360 at 11:30:48 AM IST on 17 August 2026, when the Univest screener identified the stock as trading within 2% of its 52-week high. With a market capitalisation of Rs 930.04 crore, the move puts the counter on the radar for investors tracking price strength alongside valuation and business quality in the Healthcare space.

The verified data confirms the proximity to the one-year peak, and that alone is meaningful because stocks near annual highs often attract fresh attention from market participants reviewing relative strength, valuation discipline and peer positioning. In this case, Bharat Parenterals Ltd. Share Price is drawing notice even as the company’s reported P/E stands at -60.85, while return ratios remain positive with ROE at 15.53% and ROCE at 20.24%.

For readers following Bharat Parenterals Ltd. Share Price Today, the current setup matters less as a headline and more as a data point. Univest shows a stock close to its yearly high, operating in Pharmaceuticals & Drugs, with a price-to-book ratio of 2.92 and book value per share of Rs 462.38. That combination makes Bharat Parenterals Ltd. Share Price relevant for both price-action watchers and fundamental screens.

Bharat Parenterals Ltd. Share Price Today: Within 2% of 52-Week High

Metric	Value
LTP at 2% Qualification	Rs 1,360
Market Capitalisation	Rs 930.04 crore
52-Week High Position	Trading within 2% of its 52-week high

Bharat Parenterals Ltd. (BPLPHARMA) traded at Rs 1,360. Reported volume was 397.

Bharat Parenterals Ltd. Share Price Today was Rs 1,360 at the event qualification point captured by Univest, and the key fact established by the supplied data is that the stock was trading within 2% of its 52-week high. That places the counter close to an important reference zone that many investors monitor while assessing whether market interest is being sustained over a longer period rather than limited to a single session move.

Because the screener event is based on proximity to the one-year high, Bharat Parenterals Ltd. Share Price naturally enters the conversation for traders and long-term market participants looking for stocks that are holding up near the upper end of their yearly range. Such positioning can matter because it often reflects continuing market attention, particularly when a stock with a Rs 930.04 crore market capitalisation remains near its recent highs in a closely tracked Healthcare segment.

The available data does not establish a company-specific catalyst, but it does confirm why Bharat Parenterals Ltd. Share Price is appearing in searches around yearly highs and stock analysis. At Rs 1,360, the counter is in a zone where investors may begin comparing current valuation, profitability ratios and industry benchmarks more closely. That makes the next layer of analysis important: whether the fundamentals behind Bharat Parenterals Ltd. Share Price support the attention generated by this near-52-week-high setup.

Bharat Parenterals Ltd. (BPLPHARMA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 930.04 crore
P/E Ratio	-60.85x
P/B Ratio	2.92x
ROE	15.53%
ROCE	20.24%
EPS	Rs -22.35
Book Value Per Share	Rs 462.38
Dividend Yield	0.07%

Bharat Parenterals Ltd. was valued at a P/E ratio of -60.85x, a P/B ratio of 2.92x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 15.53% and ROCE of 20.24%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs -22.35, book value per share of Rs 462.38, dividend yield of 0.07%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	-60.85x
Benchmark Median P/E	19.13x
Benchmark Average P/E	30.65x
Benchmark P/E Range	0x to 361.02x
Company P/B Ratio	2.92x
Benchmark Median P/B	1.75x
Company ROE	15.53%
Benchmark Median ROE	9.87%
Company ROCE	20.24%
Benchmark Median ROCE	12.57%
Company Market Capitalisation	Rs 930.04 crore
Benchmark Median Market Cap	Rs 137.36 crore

Bharat Parenterals Ltd. (BPLPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Bharat Parenterals Ltd. (BPLPHARMA) has a P/E ratio of -60.85x, which is below the benchmark median of 19.13x, a difference of -418.09%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Bharat Parenterals Ltd. (BPLPHARMA) has a ROE of 15.53%, which is above the benchmark median of 9.87%, a difference of +57.35%. Bharat Parenterals Ltd. (BPLPHARMA) has a ROCE of 20.24%, which is above the benchmark median of 12.57%, a difference of +61.02%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Kopran Ltd.	KOPRAN-BE	918.15	36.75	1.71	18.19	21.4
Wanbury Ltd.	WANBURY	915.43	21.3	13.64	0	87.61
Sudarshan Pharma Industries Ltd.	SUDARSHAN	906.51	36.08	2.89	11.87	13.01
Themis Medicare Ltd.	THEMISMED	964.29	24.12	2.49	17.82	18.44
Sigachi Industries Ltd.	SIGACHI	1,040.5	41.04	1.96	38.11	37.83

Bharat Parenterals Ltd. (BPLPHARMA) has a P/E ratio of -60.85x compared with the displayed peer median of 36.08x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 15.53% compares with a peer median of 17.82% across the companies shown in the table. ROCE stood at 20.24% versus the displayed peer median of 21.4%, providing a capital-efficiency comparison. Bharat Parenterals Ltd. (BPLPHARMA) has a market capitalisation of Rs 930.04 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching Bharat Parenterals Ltd.

• Bharat Parenterals Ltd. Share Price was Rs 1,360 when the Univest screener flagged the stock as trading within 2% of its 52-week high.
• The company has a market capitalisation of Rs 930.04 crore, making it meaningful enough for investors to compare against listed industry peers.
• Fundamentals are mixed: P/E is -60.85 and EPS is -22.35, while ROE at 15.53% and ROCE at 20.24% remain positive.
• P/B at 2.92 is above the same-industry median of 1.75 and average of 2.31, suggesting the market is placing a relatively higher book-value multiple on the stock.
• Within the Pharmaceuticals & Drugs peer set, Bharat Parenterals Ltd. Share Price shows competitive return ratios against several similarly sized companies.

About Bharat Parenterals Ltd.

Bharat Parenterals Ltd. operates in the Healthcare sector and is classified under the Pharmaceuticals & Drugs industry. That places the company in a segment where investors typically study earnings quality, return ratios, valuation multiples and peer comparisons closely, especially when a stock is trading near its yearly high.

Based on the supplied classification data, Bharat Parenterals Ltd. is part of an industry universe of 138 listed companies used for same-industry benchmarking on Univest, while the broader Healthcare sector comparison spans 200 companies. This context matters because Bharat Parenterals Ltd. Share Price is not being assessed in isolation; it is being compared with other listed pharmaceutical businesses on metrics such as P/E, P/B, ROE, ROCE and market capitalisation.

For investors tracking Bharat Parenterals Ltd. Stock News, the company currently stands out less because of descriptive business details in the supplied dataset and more because of its market positioning: a Rs 930.04 crore company in Pharmaceuticals & Drugs, trading near its one-year high, with a negative P/E but positive return ratios. That combination is what makes Bharat Parenterals Ltd. Share Price notable in the current screen.

Track Bharat Parenterals Ltd. Share Price on Univest

Use Bharat Parenterals Ltd. (BPLPHARMA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors who want to follow Bharat Parenterals Ltd. Share Price can use Univest to track live price moves, 52-week levels, valuation ratios, profitability indicators, sector benchmarks, peer positioning and broader market insights in one place. For readers reviewing Bharat Parenterals Ltd. Share Price Today, that consolidated view is useful because the current setup combines a near-52-week-high price position with a fundamental profile that is not straightforward.

Univest also helps users monitor how Bharat Parenterals Ltd. Share Price compares with industry medians, averages and similarly sized listed peers over time. That matters here because the stock’s Rs 1,360 event price, negative P/E and positive ROE and ROCE create a profile that benefits from regular cross-checking rather than a single-point reading.

Frequently Asked Questions

What is Bharat Parenterals Ltd. Share Price today?

Ans. Bharat Parenterals Ltd. Share Price was Rs 1,360 at 11:30:48 AM IST on 17 August 2026, which is the exact event-time price captured when the Univest screener identified the stock near its yearly high.

Why is Bharat Parenterals Ltd. Share Price in focus today?

Ans. Bharat Parenterals Ltd. Share Price is in focus because the stock was identified as trading within 2% of its 52-week high. The company also has a market capitalisation of Rs 930.04 crore in Pharmaceuticals & Drugs.

Is Bharat Parenterals Ltd. Share Price near its 52-week high?

Ans. Yes, the supplied event confirms Bharat Parenterals Ltd. Share Price was trading within 2% of its 52-week high. That is the precise screen condition recorded by Univest at the event qualification time.

What does the valuation data show for Bharat Parenterals Ltd. Share Price?

Ans. The valuation picture is mixed. Bharat Parenterals Ltd. Share Price is associated with a P/E of -60.85 and a P/B of 2.92, indicating negative earnings but a book-value multiple above the industry median.

How profitable is Bharat Parenterals Ltd. based on the supplied ratios?

Ans. The supplied profitability ratios show ROE of 15.53% and ROCE of 20.24%. Both are above the same-industry medians of 9.87% and 12.57%, respectively, which adds useful context to Bharat Parenterals Ltd. Share Price.

What do EPS, book value and dividend yield indicate here?

Ans. EPS is -22.35, which reflects negative earnings over the relevant period. Book value per share is Rs 462.38, while dividend yield is 0.07, showing a modest historical payout relative to Bharat Parenterals Ltd. Share Price.

How does Bharat Parenterals Ltd. compare with industry benchmarks?

Ans. Bharat Parenterals Ltd. is compared against 138 same-industry companies. Its P/B of 2.92 is above the median 1.75, while ROE of 15.53% and ROCE of 20.24% both sit above industry medians.

How does Bharat Parenterals Ltd. compare with similar listed peers?

Ans. Bharat Parenterals Ltd. has a market capitalisation of Rs 930.04 crore, close to peers like Kopran, Wanbury, Sudarshan Pharma and Themis Medicare. Its ROE and ROCE are competitive, but its P/E remains negative versus peers’ positive multiples.